Trial Profile
A Randomized, Open-label, Crossover Study to Investigate the Pharmacokinetic Drug Interactions and the Safety Between HGP1607 and HGP1501 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2022
Price :
$35
*
At a glance
- Drugs HGP 1501 (Primary) ; HGP 1607 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 07 Nov 2022 Status changed from not yet recruiting to completed.
- 03 Apr 2017 New trial record